Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
Rabies is a major public health problem with a fatality rate close to 100%; however, complete prevention can be achieved through pre- or post-exposure prophylaxis. The rapid fluorescent focus inhibition test (RFFIT) is one of the recommended testing methods to determine the production of neutralizin...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-12-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC5755941?pdf=render |
_version_ | 1818164222433951744 |
---|---|
author | Jihye Um Byung Chul Chun Yeong Seon Lee Kyu Jam Hwang Dong-Kun Yang Jun-Sun Park Su Yeon Kim |
author_facet | Jihye Um Byung Chul Chun Yeong Seon Lee Kyu Jam Hwang Dong-Kun Yang Jun-Sun Park Su Yeon Kim |
author_sort | Jihye Um |
collection | DOAJ |
description | Rabies is a major public health problem with a fatality rate close to 100%; however, complete prevention can be achieved through pre- or post-exposure prophylaxis. The rapid fluorescent focus inhibition test (RFFIT) is one of the recommended testing methods to determine the production of neutralizing antibodies after vaccination. Here, we report the development of a new monoclonal antibody (mAb) designed to react specifically with Rabies virus (RABV) phosphoprotein (P protein), and the evaluation of its applicability to the RFFIT and its effectiveness as a diagnostic reagent for human rabies.The mAb KGH P 16B8 was produced to target the P protein of the Korean KGH RABV strain. An indirect immunofluorescence assay (IFA) was conducted to detect various strains of RABV in various cell lines. Alexa-conjugated KGH P 16B8 (16B8-Alexa) was developed for the RFFIT. The IFA test could detect RABV up to a 1:2,500 dilution, with a detection limit comparable to that of a commercial diagnostic reagent. The sensitivity, specificity, positive predictive value, and negative predictive value of the RFFIT using 16B8-Alexa in 414 clinical specimens were 98.67%, 99.47%, 99.55%, and 98.42%, respectively. The results of the RFFIT with 16B8-Alexa were strongly correlated with those obtained using an existing commercial diagnostic reagent (r = 0.995, p<0.001).The mAb developed in this study shows high sensitivity and specificity, confirming its clinical utility with the RFFIT to measure the rabies neutralizing antibody titer and establish a diagnosis in human. Thus, 16B8-Alexa is expected to serve as an alternative diagnostic reagent that is widely accessible, with potentially broad applications beyond those of the RFFIT in Korea. Further studies with 16B8-Alexa should provide insight into the immunological mechanism of the P protein of Korean RABV. |
first_indexed | 2024-12-11T17:02:01Z |
format | Article |
id | doaj.art-93703f715cf8443f8a09d88ec148878e |
institution | Directory Open Access Journal |
issn | 1935-2727 1935-2735 |
language | English |
last_indexed | 2024-12-11T17:02:01Z |
publishDate | 2017-12-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS Neglected Tropical Diseases |
spelling | doaj.art-93703f715cf8443f8a09d88ec148878e2022-12-22T00:57:47ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352017-12-011112e000608410.1371/journal.pntd.0006084Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.Jihye UmByung Chul ChunYeong Seon LeeKyu Jam HwangDong-Kun YangJun-Sun ParkSu Yeon KimRabies is a major public health problem with a fatality rate close to 100%; however, complete prevention can be achieved through pre- or post-exposure prophylaxis. The rapid fluorescent focus inhibition test (RFFIT) is one of the recommended testing methods to determine the production of neutralizing antibodies after vaccination. Here, we report the development of a new monoclonal antibody (mAb) designed to react specifically with Rabies virus (RABV) phosphoprotein (P protein), and the evaluation of its applicability to the RFFIT and its effectiveness as a diagnostic reagent for human rabies.The mAb KGH P 16B8 was produced to target the P protein of the Korean KGH RABV strain. An indirect immunofluorescence assay (IFA) was conducted to detect various strains of RABV in various cell lines. Alexa-conjugated KGH P 16B8 (16B8-Alexa) was developed for the RFFIT. The IFA test could detect RABV up to a 1:2,500 dilution, with a detection limit comparable to that of a commercial diagnostic reagent. The sensitivity, specificity, positive predictive value, and negative predictive value of the RFFIT using 16B8-Alexa in 414 clinical specimens were 98.67%, 99.47%, 99.55%, and 98.42%, respectively. The results of the RFFIT with 16B8-Alexa were strongly correlated with those obtained using an existing commercial diagnostic reagent (r = 0.995, p<0.001).The mAb developed in this study shows high sensitivity and specificity, confirming its clinical utility with the RFFIT to measure the rabies neutralizing antibody titer and establish a diagnosis in human. Thus, 16B8-Alexa is expected to serve as an alternative diagnostic reagent that is widely accessible, with potentially broad applications beyond those of the RFFIT in Korea. Further studies with 16B8-Alexa should provide insight into the immunological mechanism of the P protein of Korean RABV.http://europepmc.org/articles/PMC5755941?pdf=render |
spellingShingle | Jihye Um Byung Chul Chun Yeong Seon Lee Kyu Jam Hwang Dong-Kun Yang Jun-Sun Park Su Yeon Kim Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT. PLoS Neglected Tropical Diseases |
title | Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT. |
title_full | Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT. |
title_fullStr | Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT. |
title_full_unstemmed | Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT. |
title_short | Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT. |
title_sort | development and evaluation of an anti rabies virus phosphoprotein specific monoclonal antibody for detection of rabies neutralizing antibodies using rffit |
url | http://europepmc.org/articles/PMC5755941?pdf=render |
work_keys_str_mv | AT jihyeum developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit AT byungchulchun developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit AT yeongseonlee developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit AT kyujamhwang developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit AT dongkunyang developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit AT junsunpark developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit AT suyeonkim developmentandevaluationofanantirabiesvirusphosphoproteinspecificmonoclonalantibodyfordetectionofrabiesneutralizingantibodiesusingrffit |